Dermatological Health in the Light of Skin Microbiome Evolution.
bacteriotherapy
dysbiosis
microorganisms
phages
probiotic
skin aging
skin conditions
skin microbiome
skin microbiota
skin transplantation
Journal
Journal of cosmetic dermatology
ISSN: 1473-2165
Titre abrégé: J Cosmet Dermatol
Pays: England
ID NLM: 101130964
Informations de publication
Date de publication:
09 Sep 2024
09 Sep 2024
Historique:
revised:
12
08
2024
received:
10
06
2024
accepted:
20
08
2024
medline:
9
9
2024
pubmed:
9
9
2024
entrez:
9
9
2024
Statut:
aheadofprint
Résumé
The complex ecosystem of the skin microbiome is essential for skin health by acting as a primary defense against infections, regulating immune responses, and maintaining barrier integrity. This literature review aims to consolidate existing information on the skin microbiome, focusing on its composition, functionality, importance, and its impact on skin aging. An exhaustive exploration of scholarly literature was performed utilizing electronic databases including PubMed, Google Scholar, and ResearchGate, focusing on studies published between 2011 and 2024. Keywords included "skin microbiome," "skin microbiota," and "aging skin." Studies involving human subjects that focused on the skin microbiome's relationship with skin health were included. Out of 100 initially identified studies, 70 met the inclusion criteria and were reviewed. Studies showed that aging is associated with a reduction in the variety of microorganisms of the skin microbiome, leading to an increased susceptibility to skin conditions. Consequently, this underlines the interest in bacteriotherapy, mainly topical probiotics, to reinforce the skin microbiome in older adults, suggesting improvements in skin health and a reduction in age-related skin conditions. Further exploration is needed into the microbiome's role in skin health and the development of innovative, microbe-based skincare products. Biotherapeutic approaches, including the use of phages, endolysins, probiotics, prebiotics, postbiotics, and microbiome transplantation, can restore balance and enhance skin health. This article also addresses regulatory standards in the EU and the USA that ensure the safety and effectiveness of microbial skincare products. This review underscores the need to advance research on the skin microbiome's role in cosmetic enhancements and tailored skincare solutions, highlighting a great interest in leveraging microbial communities for dermatological benefits.
Sections du résumé
BACKGROUND
BACKGROUND
The complex ecosystem of the skin microbiome is essential for skin health by acting as a primary defense against infections, regulating immune responses, and maintaining barrier integrity. This literature review aims to consolidate existing information on the skin microbiome, focusing on its composition, functionality, importance, and its impact on skin aging.
METHODS
METHODS
An exhaustive exploration of scholarly literature was performed utilizing electronic databases including PubMed, Google Scholar, and ResearchGate, focusing on studies published between 2011 and 2024. Keywords included "skin microbiome," "skin microbiota," and "aging skin." Studies involving human subjects that focused on the skin microbiome's relationship with skin health were included. Out of 100 initially identified studies, 70 met the inclusion criteria and were reviewed.
RESULTS
RESULTS
Studies showed that aging is associated with a reduction in the variety of microorganisms of the skin microbiome, leading to an increased susceptibility to skin conditions. Consequently, this underlines the interest in bacteriotherapy, mainly topical probiotics, to reinforce the skin microbiome in older adults, suggesting improvements in skin health and a reduction in age-related skin conditions. Further exploration is needed into the microbiome's role in skin health and the development of innovative, microbe-based skincare products. Biotherapeutic approaches, including the use of phages, endolysins, probiotics, prebiotics, postbiotics, and microbiome transplantation, can restore balance and enhance skin health. This article also addresses regulatory standards in the EU and the USA that ensure the safety and effectiveness of microbial skincare products.
CONCLUSION
CONCLUSIONS
This review underscores the need to advance research on the skin microbiome's role in cosmetic enhancements and tailored skincare solutions, highlighting a great interest in leveraging microbial communities for dermatological benefits.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.
Références
M. Eisenstein, “The Skin Microbiome,” Nature 588, no. 7838 (2020): S209, https://doi.org/10.1038/d41586‐020‐03523‐7.
E. A. Grice and J. A. Segre, “The Skin Microbiome,” Nature Reviews. Microbiology 9, no. 4 (2011): 244–253, https://doi.org/10.1038/nrmicro2537.
K. Skowron, J. Bauza‐Kaszewska, Z. Kraszewska, et al., “Human Skin Microbiome: Impact of Intrinsic and Extrinsic Factors on Skin Microbiota,” Microorganisms 9, no. 3 (2021): 543, https://doi.org/10.3390/microorganisms9030543.
P. Smythe and H. N. Wilkinson, “The Skin Microbiome: Current Landscape and Future Opportunities,” International Journal of Molecular Sciences 24, no. 4 (2023): 3950, https://doi.org/10.3390/ijms24043950.
T. A. Harris‐Tryon and E. A. Grice, “Microbiota and Maintenance of Skin Barrier Function,” Science 376, no. 6596 (2022): 940–945, https://doi.org/10.1126/science.abo0693.
M. Habeebuddin, R. K. Karnati, P. N. Shiroorkar, et al., “Topical Probiotics: More Than a Skin Deep,” Pharmaceutics 14, no. 3 (2022): 557, https://doi.org/10.3390/pharmaceutics14030557.
I. R. Serghiou, M. A. Webber, and L. J. Hall, “An Update on the Current Understanding of the Infant Skin Microbiome and Research Challenges,” Current Opinion in Microbiology 75 (2023): 102364, https://doi.org/10.1016/j.mib.2023.102364.
T. C. Scharschmidt and M. A. Fischbach, “What Lives on Our Skin: Ecology, Genomics and Therapeutic Opportunities of the Skin Microbiome,” Drug Discovery Today: Disease Mechanisms 10, no. 3 (2013): e83–e89, https://doi.org/10.1016/j.ddmec.2012.12.003.
H. Xu and H. Li, “Acne, the Skin Microbiome, and Antibiotic Treatment,” American Journal of Clinical Dermatology 20, no. 3 (2019): 335–344, https://doi.org/10.1007/s40257‐018‐00417‐3.
L. Moitinho‐Silva, F. Degenhardt, E. Rodriguez, et al., “Host Genetic Factors Related to Innate Immunity, Environmental Sensing and Cellular Functions Are Associated With Human Skin Microbiota,” Nature Communications 13, no. 1 (2022): 6204, https://doi.org/10.1038/s41467‐022‐33906‐5.
M. Boxberger, V. Cenizo, N. Cassir, and B. La Scola, “Challenges in Exploring and Manipulating the Human Skin Microbiome,” Microbiome 9, no. 1 (2021): 125, https://doi.org/10.1186/s40168‐021‐01062‐5.
Y. Yang, L. Qu, I. Mijakovic, and Y. Wei, “Advances in the Human Skin Microbiota and Its Roles in Cutaneous Diseases,” Microbial Cell Factories 21, no. 1 (2022): 176, https://doi.org/10.1186/s12934‐022‐01901‐6.
R. L. Gallo, “Human Skin Is the Largest Epithelial Surface for Interaction With Microbes,” Journal of Investigative Dermatology 137, no. 6 (2017): 1213–1214, https://doi.org/10.1016/j.jid.2016.11.045.
C. Callewaert, K. Ravard Helffer, and P. Lebaron, “Skin Microbiome and Its Interplay With the Environment,” American Journal of Clinical Dermatology 21, no. 1 (2020): 4–11, https://doi.org/10.1007/s40257‐020‐00551‐x.
Y. Zhu, X. Yu, and G. Cheng, “Human Skin Bacterial Microbiota Homeostasis: A Delicate Balance Between Health and Disease,” mLife 2, no. 2 (2023): 107–120, https://doi.org/10.1002/mlf2.12064.
S. McCarthy, M. Barrett, S. Kirthi, et al., “Altered Skin and Gut Microbiome in Hidradenitis Suppurativa,” Journal of Investigative Dermatology 142, no. 2 (2022): 459–468.e15, https://doi.org/10.1016/j.jid.2021.05.036.
E. S. Chambers and M. Vukmanovic‐Stejic, “Skin Barrier Immunity and Ageing,” Immunology 160, no. 2 (2020): 116–125, https://doi.org/10.1111/imm.13152.
H. E. Baldwin, N. D. Bhatia, A. Friedman, R. M. Eng, and S. Seite, “The Role of Cutaneous Microbiota Harmony in Maintaining a Functional Skin Barrier,” Journal of Drugs in Dermatology 16, no. 1 (2017): 12–18.
T. R. Johnson, B. I. Gómez, M. K. McIntyre, et al., “The Cutaneous Microbiome and Wounds: New Molecular Targets to Promote Wound Healing,” International Journal of Molecular Sciences 19, no. 9 (2018): 2699, https://doi.org/10.3390/ijms19092699.
A. L. Demessant‐Flavigny, S. Connétable, D. Kerob, M. Moreau, L. Aguilar, and A. Wollenberg, “Skin Microbiome Dysbiosis and the Role of Staphylococcus Aureus in Atopic Dermatitis in Adults and Children: A Narrative Review,” Journal of the European Academy of Dermatology and Venereology 37, no. Suppl 5 (2023): 3–17, https://doi.org/10.1111/jdv.19125.
C. Dessinioti and A. Katsambas, “The Microbiome and Acne: Perspectives for Treatment,” Dermatologic Therapy 14, no. 1 (2024): 31–44, https://doi.org/10.1007/s13555‐023‐01079‐8.
T. Myers, A. Bouslimani, S. Huang, et al., “A Multi‐Study Analysis Enables Identification of Potential Microbial Features Associated With Skin Aging Signs,” Frontiers in Aging 4 (2023): 1304705, https://doi.org/10.3389/fragi.2023.1304705.
Y. Ratanapokasatit, W. Laisuan, T. Rattananukrom, A. Petchlorlian, I. Thaipisuttikul, and M. Sompornrattanaphan, “How Microbiomes Affect Skin Aging: The Updated Evidence and Current Perspectives,” Life 12, no. 7 (2022): 936, https://doi.org/10.3390/life12070936.
T. Nakatsuji, J. Y. Cheng, and R. L. Gallo, “Mechanisms for Control of Skin Immune Function by the Microbiome,” Current Opinion in Immunology 72 (2021): 324–330, https://doi.org/10.1016/j.coi.2021.09.001.
J. Hurlow and D. Z. Bliss, “Dry Skin in Older Adults,” Geriatric Nursing (New York, N.Y.) 32, no. 4 (2011): 257–262, https://doi.org/10.1016/j.gerinurse.2011.03.003.
R. Jugé, P. Rouaud‐Tinguely, J. Breugnot, et al., “Shift in Skin Microbiota of Western European Women Across Aging,” Journal of Applied Microbiology 125, no. 3 (2018): 907–916, https://doi.org/10.1111/jam.13929.
B. Dréno, E. Araviiskaia, E. Berardesca, et al., “Microbiome in Healthy Skin, Update for Dermatologists,” Journal of the European Academy of Dermatology and Venereology 30, no. 12 (2016): 2038–2047, https://doi.org/10.1111/jdv.13965.
A. L. Byrd, Y. Belkaid, and J. A. Segre, “The Human Skin Microbiome,” Nature Reviews. Microbiology 16, no. 3 (2018): 143–155, https://doi.org/10.1038/nrmicro.2017.157.
M. Kano, N. Masuoka, C. Kaga, et al., “Consecutive Intake of Fermented Milk Containing Bifidobacterium Breve Strain Yakult and Galacto‐Oligosaccharides Benefits Skin Condition in Healthy Adult Women,” Bioscience of Microbiota, Food and Health 32, no. 1 (2013): 33–39, https://doi.org/10.12938/bmfh.32.33.
Y. R. Woo and H. S. Kim, “Interaction Between the Microbiota and the Skin Barrier in Aging Skin: A Comprehensive Review,” Frontiers in Physiology 15 (2024): 1322205, https://doi.org/10.3389/fphys.2024.1322205.
D. Sharma, M. M. Kober, and W. P. Bowe, “Anti‐Aging Effects of Probiotics,” Journal of Drugs in Dermatology 15, no. 1 (2016): 9–12.
L. Dimarzio, B. Cinque, F. Cupelli, C. De Simone, M. G. Cifone, and M. Giuliani, “Increase of Skin‐Ceramide Levels in Aged Subjects Following a Short‐Term Topical Application of Bacterial Sphingomyelinase From Streptococcus thermophilus,” International Journal of Immunopathology and Pharmacology 21, no. 1 (2008): 137–143, https://doi.org/10.1177/039463200802100115.
M. Notay, S. Saric‐Bosanac, A. R. Vaughn, et al., “The Use of Topical Nitrosomonas eutropha for Cosmetic Improvement of Facial Wrinkles,” Journal of Cosmetic Dermatology 19, no. 3 (2020): 689–693, https://doi.org/10.1111/jocd.13060.
L. S. Weyrich, S. Dixit, A. G. Farrer, A. J. Cooper, and A. J. Cooper, “The Skin Microbiome: Associations Between Altered Microbial Communities and Disease,” Australasian Journal of Dermatology 56, no. 4 (2015): 268–274, https://doi.org/10.1111/ajd.12253.
M. A. Rocha and E. Bagatin, “Skin Barrier and Microbiome in Acne,” Archives of Dermatological Research 310, no. 3 (2018): 181–185, https://doi.org/10.1007/s00403‐017‐1795‐3.
B. S. Kang, J. G. Seo, G. S. Lee, et al., “Antimicrobial Activity of Enterocins From Enterococcus faecalis SL‐5 Against Propionibacterium acnes, the Causative Agent in Acne Vulgaris, and Its Therapeutic Effect,” Journal of Microbiology (Seoul, Korea) 47, no. 1 (2009): 101–109, https://doi.org/10.1007/s12275‐008‐0179‐y.
Y. B. Lee, E. J. Byun, and H. S. Kim, “Potential Role of the Microbiome in Acne: A Comprehensive Review,” Journal of Clinical Medicine 8, no. 7 (2019): 987, https://doi.org/10.3390/jcm8070987.
H. B. Thio, “The Microbiome in Psoriasis and Psoriatic Arthritis: The Skin Perspective,” Journal of Rheumatology. Supplement 94 (2018): 30–31, https://doi.org/10.3899/jrheum.180133.
K. França, “Topical Probiotics in Dermatological Therapy and Skincare: A Concise Review,” Dermatologic Therapy 11, no. 1 (2021): 71–77, https://doi.org/10.1007/s13555‐020‐00476‐7.
A. Guéniche, A. Hennino, C. Goujon, et al., “Improvement of Atopic Dermatitis Skin Symptoms by Vitreoscilla filiformis Bacterial Extract,” European Journal of Dermatology 16, no. 4 (2006): 380–384.
A. Guéniche, A. C. Cathelineau, P. Bastien, et al., “Vitreoscilla filiformis Biomass Improves Seborrheic Dermatitis,” Journal of the European Academy of Dermatology and Venereology 22, no. 8 (2008): 1014–1015, https://doi.org/10.1111/j.1468‐3083.2007.02508.x.
Y. E. Chen and H. Tsao, “The Skin Microbiome: Current Perspectives and Future Challenges,” Journal of the American Academy of Dermatology 69, no. 1 (2013): 143–155.e3, https://doi.org/10.1016/j.jaad.2013.01.016.
M. J. Carvalho, A. L. S Oliveira, S. Santos Pedrosa, M. Pintado, I. Pinto‐Ribeiro, and A. R. Madureira, “Skin Microbiota and the Cosmetic Industry,” Microbial Ecology 86, no. 1 (2023): 86–96, https://doi.org/10.1007/s00248‐022‐02070‐0.
A. Bouslimani, R. da Silva, T. Kosciolek, et al., “The Impact of Skin Care Products on Skin Chemistry and Microbiome Dynamics,” BMC Biology 17, no. 1 (2019): 47, https://doi.org/10.1186/s12915‐019‐0660‐6.
C. Wallen‐Russell, “The Role of Every‐Day Cosmetics in Altering the Skin Microbiome: A Study Using Biodiversity,” Cosmetics 6, no. 1 (2019): 2, https://doi.org/10.3390/cosmetics6010002.
C. C. Ch'ng, “Rebalancing of the Skin Microbiome With an Emollient “Plus” for Effective Management of Atopic Dermatitis: A Mini Review,” Medical Journal of Malaysia 79, no. 2 (2024): 203–205.
A. Sarasati, M. H. Syahruddin, A. Nuryanti, et al., “Plant‐Derived Exosome‐Like Nanoparticles for Biomedical Applications and Regenerative Therapy,” Biomedicine 11, no. 4 (2023): 1053, https://doi.org/10.3390/biomedicines11041053.
G. Bai, T. M. Truong, G. N. Pathak, L. Benoit, and B. Rao, “Clinical Applications of Exosomes in Cosmetic Dermatology,” Skin Health and Disease (2024): e348, https://doi.org/10.1002/ski2.348.
S. O. Ghasemian, “Application of Exosomes‐Derived Mesenchymal Stem Cells in Treatment of Fungal Diseases: From Basic to Clinical Sciences,” Frontiers in Fungal Biology 2 (2021): 736093, https://doi.org/10.3389/ffunb.2021.736093.
M. A. Dagnelie, S. Corvec, A. Khammari, and B. Dréno, “Bacterial Extracellular Vesicles: A New Way to Decipher Host‐Microbiota Communications in Inflammatory Dermatoses,” Experimental Dermatology 29, no. 1 (2020): 22–28, https://doi.org/10.1111/exd.14050.
A. J. Hendricks, B. W. Mills, and V. Y. Shi, “Skin Bacterial Transplant in Atopic Dermatitis: Knowns, Unknowns and Emerging Trends,” Journal of Dermatological Science 95, no. 2 (2019): 56–61, https://doi.org/10.1016/j.jdermsci.2019.07.001.
N. Natarelli, N. Gahoonia, and R. K. Sivamani, “Bacteriophages and the Microbiome in Dermatology: The Role of the Phageome and a Potential Therapeutic Strategy,” International Journal of Molecular Sciences 24, no. 3 (2023): 2695, https://doi.org/10.3390/ijms24032695.
D. Özal, A. Arndt, and M. Thomé, “Bacteriophages and Related Endolysins for Reduction of Microorganisms in the Human Body – A Systematic Review,” GMS Hygiene and Infection Control 17 (2022): Doc01, https://doi.org/10.3205/dgkh000404.
R. Castillo‐González, I. Fernández‐Delgado, and P. Comberiati, “Bacteriotherapy With Human Skin Commensals in Atopic Dermatitis,” Allergy 77, no. 4 (2022): 1331–1333, https://doi.org/10.1111/all.15162.
D. A. R. Dewi, A. Perdiyana, N. M. Wiliantari, et al., “Managing the Skin Microbiome as a New Bacteriotherapy for Inflammatory Atopic Dermatitis,” Cureus 15, no. 11 (2023): e48803, https://doi.org/10.7759/cureus.48803.
I. Smirnova, K. Khazhomiya, P. Ptashnikova, and O. Smirnova, “Skin Microbiome and Possibilities of Bacteriotherapy (On Example of Skin Aging and Atopic Dermatitis),” Medical Alphabet no. 24 (2023): 20–26, https://doi.org/10.33667/2078‐5631‐2023‐24‐20‐26.
Y. Ito and M. Amagai, “Controlling Skin Microbiome as a New Bacteriotherapy for Inflammatory Skin Diseases,” Inflammation and Regeneration 42, no. 1 (2022): 26, https://doi.org/10.1186/s41232‐022‐00212‐y.
S. B. Park, M. Im, Y. Lee, et al., “Effect of Emollients Containing Vegetable‐Derived Lactobacillus in the Treatment of Atopic Dermatitis Symptoms: Split‐Body Clinical Trial,” Annals of Dermatology 26, no. 2 (2014): 150–155, https://doi.org/10.5021/ad.2014.26.2.150.
B. Perin, A. Addetia, and X. Qin, “Transfer of Skin Microbiota Between Two Dissimilar Autologous Microenvironments: A Pilot Study,” PLoS One 14, no. 12 (2019): e0226857, https://doi.org/10.1371/journal.pone.0226857.
I. A. Myles, K. W. Williams, J. D. Reckhow, et al., “Transplantation of Human Skin Microbiota in Models of Atopic Dermatitis,” JCI Insight 1, no. 10 (2016): e86955, https://doi.org/10.1172/jci.insight.86955.
A. von Wright, “Regulatory Aspects of Probiotics and Other Microbial Products Intended for Skin Care,” in Skin Microbiome Handbook, ed. N. Dayan (Hoboken, NJ: Wiley, 2020), 321–341.
G. L. Yingling and S. Onel, “Regulatory Agencies, Pharmaceuticals and Cosmetics,” in Kirk‐Othmer Encyclopedia of Chemical Technology, ed. Kirk‐Othmer (Hoboken, NJ: John Wiley & Sons, Ltd, 2000).
R. Arora, R. Kaur, R. Babbar, S. Dhingra, A. K. Dhingra, and A. S. Grewal, “Evolving Advances in the Cosmetic Use of Probiotics and Postbiotics: Health, Regulatory and Marketing Aspects,” Current Pharmaceutical Biotechnology 25 (2023): 1349–1361, https://doi.org/10.2174/1389201024666230703115732.
R. Hernández Medina, S. Kutuzova, K. N. Nielsen, et al., “Machine Learning and Deep Learning Applications in Microbiome Research,” ISME Communications 2, no. 1 (2022): 98, https://doi.org/10.1038/s43705‐022‐00182‐9.
G. Papoutsoglou, S. Tarazona, M. B. Lopes, et al., “Machine Learning Approaches in Microbiome Research: Challenges and Best Practices,” Frontiers in Microbiology 14 (2023): 1261889, https://doi.org/10.3389/fmicb.2023.1261889.
D. Haykal, “Unleashing the Power of Biosensors and AI in Dermatology,” Aesthetic Surgery Journal Open Forum 6 (2024): ojae030, https://doi.org/10.1093/asjof/ojae030.
N. Bhalla, P. Jolly, N. Formisano, and P. Estrela, “Introduction to Biosensors,” Essays in Biochemistry 60, no. 1 (2016): 1–8, https://doi.org/10.1042/EBC20150001.
Y. Wang, W. Zhou, C. Shen, G. Jiang, and C. Yang, “Flexible and Printable Integrated Biosensors for Monitoring Sweat and Skin Condition,” Analytical Biochemistry 661 (2023): 114985, https://doi.org/10.1016/j.ab.2022.114985.
K. Dhond, Y. Hu, and A. K. Yetisen, “Dermal Tattoo Biosensors,” Dermatologie (Heidelberg, Germany) 74, no. 10 (2023): 819–821, https://doi.org/10.1007/s00105‐023‐05195‐6.
S. L. Prescott, D. L. Larcombe, A. C. Logan, et al., “The Skin Microbiome: Impact of Modern Environments on Skin Ecology, Barrier Integrity, and Systemic Immune Programming,” World Allergy Organization Journal 10, no. 1 (2017): 29, https://doi.org/10.1186/s40413‐017‐0160‐5.